GENE ONLINE|News &
Opinion
Blog

2025-11-28|

New Nomogram Developed to Predict Severe RSV-Associated ALRTI in Asian Pediatric Populations

by GOAI
Share To

A recent study published in *BMC Pediatrics* introduces a new nomogram designed to predict severe cases of respiratory syncytial virus (RSV)-associated acute lower respiratory tract infections (ALRTI) in children across Asia. The research, led by Tian and colleagues, aims to address the significant global health burden posed by RSV, which is a leading cause of respiratory illness in young children worldwide.

The study highlights the development of this predictive tool specifically tailored for pediatric populations in Asia, where RSV-related illnesses are prevalent. Researchers focused on creating an accessible and accurate method to identify children at higher risk of severe disease. By analyzing clinical data from affected patients, the team developed a model that incorporates various factors contributing to disease severity. This nomogram could potentially aid healthcare providers in early identification and intervention for high-risk cases, though further studies may be needed to validate its effectiveness across broader populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top